Recombinant multi-species NAA25 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NAA25 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes the auxiliary subunit of the heteromeric N-terminal acetyltransferase B complex. This complex acetylates methionine residues that are followed by acidic or asparagine residues.[provided by RefSeq, Mar 2010]
The Alternative Names of target: 4833422K13Rik,A630046C11,C12orf30,C330023M02Rik,LRRGT00164,MDM20,Mdm20,Mitochondrial distribution and morphology protein 20,N-alpha-acetyltransferase 25,N-terminal acetyltransferase B complex subunit MDM20 (NatB complex subunit MDM20),N-terminal acetyltransferase B complex subunit NAA25,NAA25,NAP1,Naa25,NatB auxiliary subunit,RGD1305685,p120

Target products collectionGo to NAA25 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1231-Ag-1/ GM-Tg-hg-IP1231-Ag-2 Human NAA25 protein Human
GM-Tg-rg-IP1231-Ag-1/ GM-Tg-rg-IP1231-Ag-2 Rat NAA25 protein Rat
GM-Tg-mg-IP1231-Ag-1/ GM-Tg-mg-IP1231-Ag-2 Mouse NAA25 protein Mouse
GM-Tg-cynog-IP1231-Ag-1/ GM-Tg-cynog-IP1231-Ag-2 Cynomolgus/Rhesus macaque NAA25 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1231-Ag-1/ GM-Tg-felg-IP1231-Ag-2 Feline NAA25 protein Feline
GM-Tg-cang-IP1231-Ag-1/ GM-Tg-cang-IP1231-Ag-2 Canine NAA25 protein Canine
GM-Tg-bovg-IP1231-Ag-1/ GM-Tg-bovg-IP1231-Ag-2 Bovine NAA25 protein Bovine
GM-Tg-equg-IP1231-Ag-1/ GM-Tg-equg-IP1231-Ag-2 Equine NAA25 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1231-Ag-1/ GM-Tg-hg-IP1231-Ag-2; GM-Tg-rg-IP1231-Ag-1/ GM-Tg-rg-IP1231-Ag-2;
GM-Tg-mg-IP1231-Ag-1/ GM-Tg-mg-IP1231-Ag-2; GM-Tg-cynog-IP1231-Ag-1/ GM-Tg-cynog-IP1231-Ag-2;
GM-Tg-felg-IP1231-Ag-1/ GM-Tg-felg-IP1231-Ag-2; GM-Tg-cang-IP1231-Ag-1/ GM-Tg-cang-IP1231-Ag-2;
GM-Tg-bovg-IP1231-Ag-1/ GM-Tg-bovg-IP1231-Ag-2; GM-Tg-equg-IP1231-Ag-1/ GM-Tg-equg-IP1231-Ag-2
Products Name NAA25 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name NAA25
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NAA25 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.